跳至主要内容
临床试验/NCT02772783
NCT02772783已完成不适用

Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes Mellitus

Boston Children's Hospital1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Nucleus Accumbens Blood Flow

研究概览

简要总结

Processed carbohydrates cause rapid changes in blood sugar and have been associated with overeating and obesity. We have shown that test meals high in processed carbohydrate affect brain areas involved in addiction, craving and overeating. It is unknown whether the changes in blood sugar or the associated higher insulin levels mediate this brain activation and its likely adverse effects.

Answering this question is important for patients with type 1 diabetes who have elevated risks of obesity and disordered eating: If blood sugar is the causal mechanism, optimal insulin coverage should be protective. If insulin is the causal mechanism, however, a diet high in processed carbohydrate could predispose to overeating and weight gain, as this diet requires higher insulin doses.

To disentangle these factors, we will study brain activation and relevant blood markers in 15 men with diabetes. In 4 sessions, we will examine meals with differential carbohydrate properties while giving insulin infusions.

详细描述

A total of 15 male participants (age 18-45) with T1DM will be recruited. Participants will be enrolled in the study for a total of 1-3 months, and participate in a pre-test visit and three test visits, each after a 10-12-hr overnight fast. Participants will be instructed to consume their regular, weight maintaining diet between visits.

At the pre-test visit, the study director or PI will meet participants, confirm eligibility and obtain informed consent. Participants will receive a low glycemic index (GI) meal with optimal iv insulin coverage using a negative feedback algorithm to maintain euglycemia (euglycemic clamp). Insulin requirement will be quantified. At some time during the visit, participants will present to the BIDMC research imaging facility for a practice MRI session, during which they will undergo a brief imaging sequence to get accustomed to the scanning process and eliminate anxiety as a confounder of imaging data.

At each of 3 test visits, one of the following experimental conditions will be applied in a randomized, blinded cross-over design: (a) high GI meal with euglycemic clamp, (b) low GI meal with euglycemic clamp, (c) high GI meal with primed-variable insulin infusion at the rate established during the pre-test visit. After steady state is established, baseline laboratory evaluation and MRI imaging will be obtained, followed by the test meal. Imaging will be repeated at 1 and 4 hours postprandial. Blood samples for pertinent metabolic and hormonal parameters will be obtained every 30 minutes. Each test-visit concludes with a standard weighed meal to quantify ad-libitum intake.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Type 1 diabetes for a minimum of 3 years
  • BMI 20-35 kg/m2
  • Use of insulin pump
  • Willing and able to: Maintain weight and document for duration of the study

排除标准

  • Insulin resistance (current insulin requirement > 1.5 U/kg/d)
  • Insulin requirement < 0.5 unit/kg/day (cut-off for preserved beta-cell function)
  • HbA1C ≥ 8.0%
  • DKA within 2 months
  • Frequent hypoglycemia (BG <50 mg/dl), > 3 times per week
  • Fluctuations in body weight >10% over preceding year
  • Smoking or illicit substance abuse
  • High levels of physical activity (≥60 minutes per day, ≥ 4 days per week)
  • Current weight loss diet
  • Medical problems, medications or dietary supplements that may affect metabolism, insulin action, body weight, appetite, energy expenditure, or gastrointestinal absorption (e.g. celiac disease)
  • Allergies to compounds or intolerance of the liquid meals
  • MRI exclusion criteria
  • Other conditions according to self-report that would prohibit participation based and researcher assessment

研究组 & 干预措施

high GI meal, euglycemic insulin clamp

Experimental

A nutritional shake with high GI will be consumed. Regular insulin will be administered intravenously according to a negative feedback algorithm to maintain euglycemia.This condition results in euglycemia with high insulin levels.

干预措施: high GI meal (Other)

high GI meal, euglycemic insulin clamp

Experimental

A nutritional shake with high GI will be consumed. Regular insulin will be administered intravenously according to a negative feedback algorithm to maintain euglycemia.This condition results in euglycemia with high insulin levels.

干预措施: euglycemic insulin clamp (Drug)

high GI meal, fixed insulin infusion

Experimental

A nutritional shake with high GI will be consumed. Regular insulin will be administered intravenously at a rate previously established to maintain euglycemia after a low glycemic index meal. This condition results in moderate hyperglycemia with low insulin levels.

干预措施: high GI meal (Other)

high GI meal, fixed insulin infusion

Experimental

A nutritional shake with high GI will be consumed. Regular insulin will be administered intravenously at a rate previously established to maintain euglycemia after a low glycemic index meal. This condition results in moderate hyperglycemia with low insulin levels.

干预措施: primed-variable insulin infusion (Drug)

low GI meal, euglycemic insulin clamp

Active Comparator

A nutritional shake with low GI will be consumed. Regular insulin will be administered intravenously according to a negative feedback algorithm to maintain euglycemia. This condition results in euglycemia with low insulin levels.

干预措施: low GI meal (Other)

low GI meal, euglycemic insulin clamp

Active Comparator

A nutritional shake with low GI will be consumed. Regular insulin will be administered intravenously according to a negative feedback algorithm to maintain euglycemia. This condition results in euglycemia with low insulin levels.

干预措施: euglycemic insulin clamp (Drug)

结局指标

主要结局

Nucleus Accumbens Blood Flow

时间窗: 4 hrs postprandial

Cerebral blood flow in the right and left nucleus accumbent was measured by arterial spin labeling (MRI). Blood flow was normalized for whole brain perfusion and corrected for baseline perfusion in the respective brain area and meal order, as per our a priori statistical analysis plan.

次要结局

  • Nucleus Accumbens Blood Flow(1 hr postprandial)
  • Blood Flow in Other Brain Areas Involved in Intake Regulation - Dorsal Caudate(4 hrs postprandial)
  • Functional Connectivity of Nucleus Accumbens, Hypothalamus and Other Brain Areas Involved in Intake Regulation(1 hr postprandial)
  • Blood Flow in Other Brain Areas Involved in Intake Regulation - Ventrolateral Striatum(1 hr postprandial)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Belinda Lennerz

Instructor in Pediatric Endocrinology

Boston Children's Hospital

研究点 (1)

Loading locations...

相似试验